| EXC |
Report |
Adj. Operating EPS (Q2 2026) |
BEAT |
pred ~$0.44 vs. cons $0.435 |
MEDIUM |
| EXC |
Report |
Total Operating Revenues (Q2 2026) |
IN-LINE |
pred ~$5.65B vs. cons $5.69B |
MEDIUM |
| EXC |
Report |
PECO Regulatory Tone / O&M Progress |
IN-LINE |
stable tone, no new negative vs. cautious-but-stable expectation |
MEDIUM |
| EXC |
Guide |
Adj. Operating EPS (FY 2026) |
UNCHANGED |
guide $2.81-$2.91 (mid $2.86) vs. cons $2.853 |
HIGH |
| EXC |
Guide |
Long-term EPS Growth (2025-2029) |
UNCHANGED |
reaffirm near top end of 5-7% vs. embedded in estimates |
HIGH |
| EXC |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.0% |
— |
MEDIUM |
| EXC |
Return |
5-day cumulative residual |
-2.5% (FADE) |
FADE — weather/timing beat non-recurring; FY reaffirm no new info; sell side won't revise up; pre-run deflates over 5 days |
MEDIUM |